Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.

Matsukura S, Knowles SR, Walsh S, Shear NH.

Arch Dermatol. 2012 Jun;148(6):734-9. doi: 10.1001/archdermatol.2011.3320. Erratum in: Arch Dermatol. 2012 Sep 1;148(9):1012. Dosage error in article text. Arch Dermatol. 2012 Aug;148(8):970. Dosage error in article text.

PMID:
22351790
[PubMed - indexed for MEDLINE]
2.

Management of pemphigus in pediatric patients.

Gürcan H, Mabrouk D, Razzaque Ahmed A.

Minerva Pediatr. 2011 Aug;63(4):279-91. Review.

PMID:
21909064
[PubMed - indexed for MEDLINE]
3.

Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature.

Cianchini G, Corona R, Frezzolini A, Ruffelli M, Didona B, Puddu P.

Arch Dermatol. 2007 Aug;143(8):1033-8. Review.

PMID:
17709662
[PubMed - indexed for MEDLINE]
4.

Current therapy of the pemphigus group.

Kasperkiewicz M, Schmidt E, Zillikens D.

Clin Dermatol. 2012 Jan-Feb;30(1):84-94. doi: 10.1016/j.clindermatol.2011.03.014. Review.

PMID:
22137231
[PubMed - indexed for MEDLINE]
5.

Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature.

Fuertes I, Guilabert A, Mascaró JM Jr, Iranzo P.

Dermatology. 2010 Aug;221(1):13-6. doi: 10.1159/000287254. Epub 2010 Apr 9. Review.

PMID:
20389028
[PubMed - indexed for MEDLINE]
6.

Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?

Nigam R, Levitt J.

J Drugs Dermatol. 2012 May;11(5):622-5. Review.

PMID:
22527431
[PubMed - indexed for MEDLINE]
7.

Treatment of bullous pemphigoid with rituximab: critical analysis of the current literature.

Shetty S, Ahmed AR.

J Drugs Dermatol. 2013 Jun 1;12(6):672-7. Review.

PMID:
23839185
[PubMed - indexed for MEDLINE]
8.

Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases.

Miserocchi E, Pontikaki I, Modorati G, Gattinara M, Meroni PL, Gerloni V.

Autoimmun Rev. 2011 Nov;11(1):35-9. doi: 10.1016/j.autrev.2011.07.001. Epub 2011 Jul 13. Review.

PMID:
21763790
[PubMed - indexed for MEDLINE]
9.

Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature.

Kong WY, Swaminathan R, Irish A.

Int Urol Nephrol. 2013 Jun;45(3):795-802. doi: 10.1007/s11255-012-0206-0. Epub 2012 Jul 15. Review.

PMID:
22798030
[PubMed - indexed for MEDLINE]
10.

[Treatment of severe refractory pemphigus vulgaris with rituximab].

Pitarch G, Sánchez-Carazo JL, Pardo J, Torrijos A, Roche E, Fortea JM.

Actas Dermosifiliogr. 2006 Jan-Feb;97(1):48-51. Review. Spanish.

PMID:
16540052
[PubMed - indexed for MEDLINE]
11.

The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.

Allen KJ, Wolverton SE.

J Drugs Dermatol. 2007 Sep;6(9):883-9. Review.

PMID:
17941359
[PubMed - indexed for MEDLINE]
12.

Rituximab in severe pemphigus.

Schmidt E, Goebeler M, Zillikens D.

Ann N Y Acad Sci. 2009 Sep;1173:683-91. doi: 10.1111/j.1749-6632.2009.04744.x. Review.

PMID:
19758216
[PubMed - indexed for MEDLINE]
13.

Resolution of Hypoprothrombinemia-Lupus Anticoagulant Syndrome (HLAS) after multidrug therapy with rituximab: a case report and review of the literature.

Paschal RD, Neff AT.

Haemophilia. 2013 Mar;19(2):e62-5. doi: 10.1111/hae.12027. Epub 2012 Sep 19. Review.

PMID:
22989209
[PubMed - indexed for MEDLINE]
14.

Maintaining hemostasis in acquired von Willebrand syndrome: a review of intravenous immunoglobulin and the importance of rituximab dose scheduling.

Kanakry JA, Gladstone DE.

Transfusion. 2013 Aug;53(8):1730-5. doi: 10.1111/trf.12017. Epub 2012 Dec 17. Review.

PMID:
23252513
[PubMed - indexed for MEDLINE]
15.

Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature.

Shetty S, Ahmed AR.

J Am Acad Dermatol. 2013 Mar;68(3):499-506. doi: 10.1016/j.jaad.2012.10.018. Epub 2012 Nov 27. Review.

PMID:
23200198
[PubMed - indexed for MEDLINE]
16.

The actual management of pemphigus.

Daniel BS, Murrell DF.

G Ital Dermatol Venereol. 2010 Oct;145(5):689-702. Review.

PMID:
20930702
[PubMed - indexed for MEDLINE]
17.

[Beneficial effects of rituximab in the treatment of refractory nephrotic syndrome].

Imai E.

Nihon Jinzo Gakkai Shi. 2012;54(5):593-7. Review. Japanese. No abstract available.

PMID:
22991838
[PubMed - indexed for MEDLINE]
18.

Effect of concomitant statin use on rituximab treatment for pemphigus and pemphigoid disorders: a case-based review.

Heelan K, Knowles S, Walsh S, Shear NH.

J Eur Acad Dermatol Venereol. 2014 Apr;28(4):520-2. doi: 10.1111/jdv.12217. Epub 2013 Jul 24. Review. No abstract available.

PMID:
23888984
[PubMed - indexed for MEDLINE]
19.

A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab.

Ahmed AR, Shetty S.

Autoimmun Rev. 2015 Apr;14(4):323-331. doi: 10.1016/j.autrev.2014.12.002. Epub 2014 Dec 11. Review.

PMID:
25499920
[PubMed - as supplied by publisher]
20.

Indications for use and safety of rituximab in childhood renal diseases.

Tullus K, Marks SD.

Pediatr Nephrol. 2013 Jul;28(7):1001-9. doi: 10.1007/s00467-012-2260-3. Epub 2012 Sep 21. Review.

PMID:
22992983
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk